Pertuzumab: Unprecedented benefit in human epidermal growth factor receptor 2-positive breast cancer

Pertuzumab: Unprecedented benefit in human epidermal growth factor receptor 2-positive breast cancer

Human epidermal growth factor receptor 2 (HER2)-positive breast cancer is a more aggressive subtype of breast cancer and targeting the HER2 receptor has proven effective in improving the prognosis of these patients. Pertuzumab, a recombinant humanized monoclonal antibody and the first in a class of...

Full description

Bibliographic Details
Main Authors: Amit Rauthan, Palanki Satya Dattatreya, Manish Singhal, Ram Prabu, Siddharth Naik, Anil Kukreja
Format: Article
Language:English
Published: Thieme Medical Publishers, Inc. 2015-07-01
Series:Asian Journal of Oncology
Subjects:
breast cancer
human epidermal growth factor receptor 2
pertuzumab
Online Access:http://www.thieme-connect.de/DOI/DOI?10.4103/2454-6798.173299

Internet

http://www.thieme-connect.de/DOI/DOI?10.4103/2454-6798.173299

Similar Items